https://sputnikglobe.com/20240212/drugs-for-western-pharma-firms-allegedly-tested-on-mariupol-psychiatric-patients-for-years-1116735193.html
West’s Big Pharma Conducted Drug Testing on Mariupol's Psychiatric Patients for Years
West’s Big Pharma Conducted Drug Testing on Mariupol's Psychiatric Patients for Years
Sputnik International
Rheumatological drugs had been allegedly tested for several years on patients of the Mariupol hospital's psychiatric ward with the assistance of Ukrainian officials, according to documents seen by Sputnik.
2024-02-12T02:43+0000
2024-02-12T02:43+0000
2024-02-13T10:53+0000
world
mariupol
astrazeneca
pfizer
samsung
drugs
https://cdn1.img.sputnikglobe.com/img/07e7/0a/14/1114367550_0:0:1280:720_1920x0_80_0_0_6980f2a1e0cb8d8efc5802111943a327.jpg
During the restoration of hospital No. 7 in Mariupol, a construction team stumbled upon a collection of documents in the basement. These findings of interest turned out to be records from a hospital psychiatric ward, dating from 2008 to 2016. Upon examination, these documents detailed a series of human experiments involving certain undisclosed drugs, which were solely identified by numbers.The primary purpose of the research was to evaluate the effectiveness of the drug in relation to the proportion of patients who achieved the response according to the criteria of the American College of Rheumatology (ACR). In addition, boxes containing many ready-made envelopes from logistics companies and containers for biomaterial with recipient addresses of laboratories in Switzerland, the United Kingdom and the United States were found on the site of the hospital.
https://sputnikglobe.com/20220616/us-tested-neuromodulators-on-socially-vulnerable-ukrainians---russian-defense-ministry-1096382173.html
https://sputnikglobe.com/20231113/russias-revelations-on-ukraine-biolabs-force-us-to-curtail-global-biowarfare-research-1114924367.html
mariupol
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
2024
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
News
en_EN
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
drugs, us used drugs on ukrainians, ukraine drugs its people, illegal use of medical drugs, mariupol, ukraine russia fight for mariupol
drugs, us used drugs on ukrainians, ukraine drugs its people, illegal use of medical drugs, mariupol, ukraine russia fight for mariupol
West’s Big Pharma Conducted Drug Testing on Mariupol's Psychiatric Patients for Years
02:43 GMT 12.02.2024 (Updated: 10:53 GMT 13.02.2024) MARIUPOL (Sputnik) -According to documents obtained by Sputnik, major Western pharmaceutical companies, with the assistance of Ukrainian officials, purportedly conducted testing of rheumatological drugs on patients in a Mariupol psychiatric ward for several years.
During the restoration of hospital No. 7 in Mariupol, a construction team stumbled upon a collection of documents in the basement.
These findings of interest turned out to be records from a hospital psychiatric ward, dating from 2008 to 2016. Upon examination, these documents detailed a series of human experiments involving certain undisclosed drugs, which were solely identified by numbers.
The primary purpose of the research was to evaluate the effectiveness of the drug in relation to the proportion of patients who achieved the response according to the criteria of the American College of Rheumatology (ACR).
Companies including Pfizer, AstraZeneca, Celltrion, Novatris International AG, IQVIA, Sanofi, Galapagos NV, Janssen Pharmaceuticals, AbbottLaboratories, Covance, Merck KGaA, CentocorBiopharmaceutical and a biopharmaceutical branch of Samsung were mentioned in the documents.
In addition, boxes containing many ready-made envelopes from logistics companies and containers for biomaterial with recipient addresses of laboratories in Switzerland, the United Kingdom and the United States were found on the site of the hospital.
13 November 2023, 14:01 GMT
